Copy

A meeting of minds

Beyond the blueprint

It has been one year since we launched our Third Expert Report (Diet, Nutrition, Physical Activity and Cancer: a Global Perspective) along with our blueprint to beat cancer. Our US charity, the American Institute for Cancer Research (AICR), recently held their annual conference, and the theme this year was Beyond the blueprint.

The conference was a huge success, and brought together experts from a wide breadth of cancer prevention and survival disciplines; from pre-clinical and clinical scientists to health professionals.

In particular, the conference presented for the first time the development of a standardised WCRF/AICR score to measure adherence to the 2018 Cancer Prevention Recommendations in epidemiological studies; giving more comparable results of the impact they have in reducing cancer risk.

Do our Cancer Prevention Recommendations work?

The 72nd World Health Assembly

This year the World Health Assembly focused on Universal Health Coverage. Our Policy and Public Affairs team attended the Assembly in Geneva last week to ensure that non-communicable diseases and prevention were kept on the global health agenda and at the forefront of health policy and conversations.

Read the statements that we made at the Assembly »

Molecules in blood may predict cancer risk

Prostate cancer is the fourth most common cancer, with around 1.3m cases diagnosed in 2018. A new study, part-funded by WCRF and published in the International Journal of Cancer, suggests molecules in the blood, known as metabolites, may be able to predict aggressive prostate cancer risk.

Read the results and conclusions of this study »

Facebook
Twitter
Blog
Copyright © 2019 World Cancer Research Fund International, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

We are a not-for-profit organisation that leads and unifies a network of cancer prevention charities with a global reach. These charities are the American Institute for Cancer Research in the US, World Cancer Research Fund UK, Wereld Kanker Onderzoek Fonds in the Netherlands and World Cancer Research Fund Hong Kong.